The Gpg1 protein is a G␥ subunit mimic implicated in the G-protein glucose-signaling pathway in Saccharomyces cerevisiae, and its function is largely unknown. Here we report that Gpg1 blocks the maintenance of [PSI ؉ ], an aggregated prion form of the translation termination factor Sup35. Although the GPG1 gene is normally not expressed, over-expression of GPG1 inhibits propagation of not only [PSI ؉ ] but also [PIN ؉ ], [URE3] prions, and the toxic polyglutamine aggregate in S. cerevisiae. Over-expression of Gpg1 does not affect expression and activity of Hsp104, a protein-remodeling factor required for prion propagation, showing that Gpg1 does not target Hsp104 directly. Nevertheless, prion elimination by Gpg1 is weakened by over-expression of Hsp104. Importantly, Gpg1 protein is prone to self-aggregate and transiently colocalized with Sup35NM-prion aggregates when expressed in [PSI ؉ ] cells. Genetic selection and characterization of loss-of-activity gpg1 mutations revealed that multiple mutations on the hydrophobic one-side surface of predicted ␣-helices of the Gpg1 protein hampered the activity. Prion elimination by Gpg1 is unaffected in the gpa2⌬ and gpb1⌬ strains lacking the supposed physiological G-protein partners of Gpg1. These findings suggest a general inhibitory interaction of the Gpg1 protein with other transmissible and nontransmissible amyloids, resulting in prion elimination. Assuming the ability of Gpg1 to form G-protein heterotrimeric complexes, Gpg1 is likely to play a versatile function of reversing the prion state and modulating the G-protein signaling pathway.
The Gpg1 protein is a G␥ subunit mimic implicated in the G-protein glucose-signaling pathway in Saccharomyces cerevisiae, and its function is largely unknown. Here we report that Gpg1 blocks the maintenance of [PSI ؉ ], an aggregated prion form of the translation termination factor Sup35. Although the GPG1 gene is normally not expressed, over-expression of GPG1 inhibits propagation of not only [PSI ؉ ] but also [PIN ؉ ], [URE3] prions, and the toxic polyglutamine aggregate in S. cerevisiae. Over-expression of Gpg1 does not affect expression and activity of Hsp104, a protein-remodeling factor required for prion propagation, showing that Gpg1 does not target Hsp104 directly. Nevertheless, prion elimination by Gpg1 is weakened by over-expression of Hsp104. Importantly, Gpg1 protein is prone to self-aggregate and transiently colocalized with Sup35NM-prion aggregates when expressed in [PSI ؉ ] cells. Genetic selection and characterization of loss-of-activity gpg1 mutations revealed that multiple mutations on the hydrophobic one-side surface of predicted ␣-helices of the Gpg1 protein hampered the activity. Prion elimination by Gpg1 is unaffected in the gpa2⌬ and gpb1⌬ strains lacking the supposed physiological G-protein partners of Gpg1. These findings suggest a general inhibitory interaction of the Gpg1 protein with other transmissible and nontransmissible amyloids, resulting in prion elimination. Assuming the ability of Gpg1 to form G-protein heterotrimeric complexes, Gpg1 is likely to play a versatile function of reversing the prion state and modulating the G-protein signaling pathway.
[PIN ϩ ] ͉ [PSI ϩ ] ͉ [URE3] ͉ Gpg1 ͉ yeast prion P rions are infectious, self-propagating protein conformations, behaving as a ''protein only'' genetic element (1) . The first characterized prion, mammalian PrP Sc , is the pathogenic agent of a series of neurodegenerative disorders (2) (6) is a prion form (3, (7) (8) (9) of the polypeptide release factor Sup35 (eRF3) that is essential for terminating protein synthesis at stop codons (8, 10, 11) . When Sup35 is in the [PSI ϩ ] state, ribosomes often fail to release polypeptides at stop codons, causing a non-Mendelian trait easily detectable by nonsense suppression (9, 12, 13) .
The [PSI ϩ ]-mediated suppression of auxotrophic markers ade1-14 or ade2-1 (nonsense alleles) have been widely used to select for and study [ (14, 15) . By using this tool, we have isolated multiple chromosomal hsp104 mutations (14) that revert [PSI ϩ ], and an N-terminal deletion mutant of Rnq1, Rnq1⌬100, that eliminates [PSI ϩ ] when expressed from a multicopy plasmid (15) . To our surprise, one [PSI ϩ ]-eliminating clone isolated in this selection encoded a G-protein ␥ subunit homolog, Gpg1, of S. cerevisiae (16) .
S. cerevisiae possess two known G-protein-medicated signaling pathways to detect extracellular pheromones to activate an MAPK cascade, and to detect glucose to activate adenylate cyclase to produce a cAMP signal (17, 18) . Typically, G proteins function as heterotrimeric complexes, composed of G␣, G␤, and G␥ subunits, which are activated when GTP binds to and replaces bound GDP on the G␣ subunit to cause its dissociation from the G␤␥ dimer. S. cerevisiae has two G␣ proteins, Gpa1 and Gpa2, which have been shown to regulate mating and glucose/ cAMP-signaling pathways, respectively (18) . Gpg1 is a G␥-subunit mimic found in a G␤␥-like dimer associated with Gpa2 (16) . However, the role of Gpg1 in glucose signaling or any cellular regulation is largely unknown. In this study, we found that Gpg1 functions to eliminate known yeast prions or amyloids, suggesting a unique functional correlation between the Gprotein signaling pathway and prion propagation in yeast. (14) . By using suppression as a tool, we selected S. cerevisiae genes which, when over-expressed on a plasmid, results in [PSI ϩ ] elimination (15) . Of these, one plasmid clone, pN5, contained GPG1 and one other protein-coding sequence (Fig. 1A) . Subcloning segments of this construct [see supporting information (SI) Text] revealed that the GPG1 gene, expressed from the strong constitutive GPD promoter in plasmid pGPG1, is solely responsible for conferring 5-FOA resistance through [PSI ϩ ] elimination (see Fig. 1 A) .
Results
Plasmid pGPG1 also reverses the Ade ϩ phenotype of the NPK265 strain ([PSI ϩ ] ade1-14 nonsense allele), resulting in a buildup of adenine metabolites that cause cells to turn red on rich media (Fig. 1B Left) 1C) . In contrast to Gpg1 over-expression, the null gpg1⌬ mutation did not affect [PSI ϩ ] (Fig. 1D) . Western blotting using anti-Gpg1 antibody revealed that pGPG1-bearing transformants produced an excess of Gpg1 with a molecular mass of Ϸ15 kDa (Fig. 1E) . We confirmed the absence of Gpg1 in the gpg1⌬ strain and, under our growth conditions, Gpg1 wasn't detectable in the wild-type strain in the absence of pGPG1. monitored by using a fusion of Rnq1 and green fluorescent protein (Rnq1-GFP) expressed from the CUP1 promoter. Rnq1-GFP formed foci with no diffuse fluorescence in the absence of pGPG1, whereas it was diffusely distributed in the presence of pGPG1 ( Fig. 2A) . In accordance with this finding, SDS-stable polymers of Rnq1 in [PIN ϩ ], a prion-specific aggregate detectable by semidenaturing detergent-agarose gel electrophoresis (SDD-AGE) (21) , were eliminated on transformation with pGPG1 ( Fig. 2B ; note that the absence of Rnq1 polymers was confirmed after segregation of pGPG1 in 3 independent segregants). These results indicate that Gpg1 inhibits the maintenance of [PIN ϩ ].
Expression of Gpg1 Eliminates [PIN
[URE3] is the prion form of Ure2 (3), which is a regulator of nitrogen metabolism (22 (9, 27, 28) . To examine whether prion elimination by Gpg1 is mediated through disabled functionality of Hsp104 or not, we first monitored the cellular level of Hsp104 in NPK265 cells ([PSI ϩ ]) transformed with pGPG1. Western blotting using antiHsp104 antibody revealed that pGPG1 does not change the cellular abundance of Hsp104 (Fig. 3A) . Then, the activity of Hsp104 in these transformants was examined by monitoring thermotolerance because Hsp104 is a heat-inducible protein required for thermotolerance and acts to resolubilize protein aggregates generated by severe stress, thereby allowing yeast to survive an otherwise lethal stress (29, 30) . To measure thermotolerance, yeast cultures were exposed to 37°C for 60 min as a pretreatment to induce the heat-shock response, then incubated at 50°C for 20 min. The extent of survival was determined from 5-fold serial dilutions spotted to YPDϩade plates at 30°C (Fig.  3B) . In contrast to the hsp104⌬ strain that shows no thermotolerance, pGPG1-bearing NPK265 strain showed no change in thermotolerance compared to the pGPG1-free strains. These results clearly demonstrate that prion elimination by Gpg1 is not caused by reduced functionality of Hsp104.
Prion-Eliminating Activity of Gpg1 Is Weakened by Over-Expression of
Hsp104. Although expression and activity of Hsp104 are not affected by Gpg1, it remains to be tested if the action of Hsp104 (31) (32) (33) . As reported, Hsp104 over-expression did not affect the [URE3] state (i.e., white colonies) in the absence of pGPG1; however, it impaired Gpg1's ability to eliminate [URE3], leaving the majority of colonies white ( Fig. 3C ; semiquantitative estimation in Fig.  3D) . A similar impairment of Gpg1 activity by Hsp104 was also observed in the [PIN ϩ ] strain, allowing the formation of Rnq1-GFP foci and SDS-stable Rnq1 polymers (Fig. 3 E and F) . These findings suggest that Gpg1 and Hsp104 act oppositely at the same site, or in the same pathway during prion propagation. A similar compensatory effect of over-expressing Hsp104 was observed in [URE3] prion elimination by Rnq1⌬100, another prioneliminating agent (Fig. S2 ).
Cellular Colocalization of Gpg1 and Sup35NM Aggregates. We have observed previously that Rnq1⌬100 is prone to self-aggregate and is occasionally colocalized with Sup35NM aggregates when expressed in [PSI ϩ ] cells (15) . We found a similar protein tendency in Gpg1. When Gpg1 is expressed in a wild-type S. cerevisiae strain and its cell lysate is fractionated by a mediumspeed (12,000 ϫ g) centrifugation, Gpg1 is always found in pellet (Fig. 4A) , showing that Gpg1 is prone to self-aggregate. However, the Gpg1 aggregate exhibits distinct properties compared with prion aggregates because it is SDS-unstable (as examined by the SDD-AGE analysis) (Fig. 4B) and is relatively diffuse compared with prion foci (as monitored by Gpg1-CFP fluorescence analysis) (shown below in Fig. 4C and Fig. S3) Fig. 1C . Reproducibility was confirmed in 3 independent segregants. The presence or absence of SDS-stable Rnq1 polymers in the above NPK200 transformants was analyzed by SDD-AGE as described in Fig. 2 .
strains. [Note that a direct fusion of Gpg1 to CFP leads to inactivation of Gpg1, and a peptide linker between Gpg1 and CFP is essential to maintain the activity (data not shown).
Gpg1-CFP is also pelletable at 12,000 ϫ g (Fig. S4 ).] Confocal fluorescence microscopy showed that although NM-YFP forms dot-like foci in the absence of Gpg1-CFP, it accumulates in the large, mostly peripherally located (but not filamentous) structures mostly colocalized with Gpg1-CFP aggregates 6 h after induction of Gpg1-CFP, and became disperse 24 h after the induction (see Fig. 4C and Fig. S3 ; note that a wider field image is presented in Fig. S3 and the indicated box-field image is presented in Fig. 4C ). It is noteworthy that strand-like foci of NM-YFP appeared 6 h after induction of Gpg1-CFP (see Fig. 4C and Fig. S3 ), which are rarely seen in any experimental conditions except for wild-type Gpg1 coexpression. These findings are interpreted as indicating a direct transient association of Sup35NM with Gpg1 aggregates during [PSI ϩ ] elimination.
Loss-of-Activity gpg1 Mutations and Protein Architecture. To prove the direct involvement of Gpg1 and to assess the protein domain or residues crucial for prion elimination, loss-of-activity mutants of Gpg1 were isolated from colonies that remained white after transformation of strain NPK265 ([PSI ϩ ] ade1-14; white) with a PCR mutated GPG1 plasmid (see Methods). Plasmid DNAs that gave a reproducible phenotype were characterized by DNA sequencing. Of the numerous independent isolates examined, we identified 14 distinct amino acid substitutions that impaired the ability of Gpg1 to eliminate [PSI ϩ ] (Fig. 5A ). There was phenotypic diversity in the identified gpg1 mutants, with some mutants giving rise to all white colonies whereas others gave rise to a mixture of white and red colonies (see Fig. 5A ). The abundance of mutant Gpg1 proteins in these transformants did not change appreciably (Fig. 5B) as examined by the SDD-AGE analysis, GFP fluorescence, and colony-color assay ( Fig. 5C-E ; data summarized in Table S1 ). Three representative mutants, L72S, L87P, and D113G, were examined further. Centrifugation assay indicated that these Gpg1s are pelletable at 12,000 ϫ g, similar to wild-type Gpg1 (Fig. S5A) . Confocal microscopy showed that [PSI ϩ ] NM-YFP aggregates underwent a morphological change from dot-like foci to slightly diffuse foci 6 h after induction of mutant Gpg1-CFPs, and NM-YFP and mutant Gpg1-CFPs are mostly colocalized (Fig. S5B) . NM-YFP foci, however, did not become fully disperse 24 h after the induction, unlike the wild-type Gpg1 (data not shown). These findings suggest that the disabled Gpg1 proteins could interact, directly or indirectly, with [PSI ϩ ] Sup35NM aggregates and remain a residual activity to trigger prion elimination only prematurely.
The hydropathy profile of Gpg1 reveals the protein to contain 4 hydrophobic regions, I through IV, with many loss-of-activity substitutions localized to the relatively hydrophobic regions (Fig.  6 A and B) . Secondary protein structure predictions show that Gpg1 is rich in ␣-helical structures, ␣1 through ␣6, and 10 of 14 substitutions are mapped to 2 major ␣ helices, ␣2 and ␣4 (see Fig.   Fig. 4 . Gpg1 aggregation and transient colocalization of Sup35NM with Gpg1 aggregates. (A) Self-aggregation of Gpg1 protein. Cell lysates of strain NPK564 transformed with pGPG1 were fractionated by centrifugation at 12,000 ϫ g, and each fraction was separated by SDS/PAGE and immunoblotted with anti-Gpg1 and anti-Pgk1 antibodies. Fractions: P, pellet; S, supernatant; W, whole lysate. (B) SDS sensitivity of Gpg1 aggregates. NPK564 ([psi Ϫ ]) and NPK265 ([PSI ϩ ]) cells transformed with pGPG1 were harvested and lysed, and equal amounts of total protein from lysates were analyzed by SDD-AGE (1% SDS). Gpg1 was detected by immunoblotting using polyclonal rabbit antiGpg1 antibody. M denotes a monomer fraction. (C) The [PSI ϩ ] strain (NPK265) was transformed with pRS424CUP1p-Gpg1-CFP and pRS413CUP1p-NM-YFP. These transformants were grown to early log-phase and supplemented with 50-M CuSO4, followed by growth for 6 and 24 h. Shown are differential interference contrast images and confocal fluorescent images of CFP (green), YFP (red), and their merge in which colocalization of Gpg1-CFP and NM-YFP is shown by yellow. NM-YFP coalesced into strand-like fluorescent foci at 6 h after induction and was diffusely distributed in the cytoplasm at 24 h after induction. 6B). These two ␣ helices are amphiphilic in nature, with asymmetric distribution of nonpolar and hydrophilic amino acid residues around the helices, as shown in the helical wheel projection (Fig. 6C) . Importantly, most of the mutations are localized to one side of the hydrophobic surfaces of ␣2 and ␣4 (see Fig. 6C ), suggesting that the hydrophobic surfaces could be involved in protein-protein interactions and that the loss-ofactivity substitutions would disable these protein interactions.
Effect of G-Protein ␣ and ␤ Subunit Deletions on Gpg1 Activity. To clarify whether Gpg1's partners in the glucose-signaling pathway (i.e., G-protein ␣ and ␤ subunits) are involved in prion elimination by Gpg1, we constructed chromosomal G␣ and G␤ gene deletions, gpa2⌬ and gpb1⌬, respectively, and examined their effects by genetic manipulations. First, we failed to find any significant change in the frequency of [PSI ϩ ] maintenance in gpa2⌬ and gpb1⌬ deficient strains (data not shown). Second, Gpg1's ability to eliminate [PSI ϩ ] was unaffected in gpa2⌬ and gpb1⌬ strains (Fig. S6) . Although the gpb2⌬ construct remains to be tested, it seems unlikely that the G-protein complex containing Gpg1 plays a direct role in prion elimination.
Discussion
In this study, we isolated a unique general antagonist of prion propagation, Gpg1, by using the ura3-197 (nonsense mutation)-based selection (14 It is highly surprising that a component of the G-protein signaling pathway, Gpg1, plays a negative role in the prion propagation in yeast. Gpg1 is a small, 126-residue protein, and has been isolated as a G␥ subunit mimic that forms a G␤␥-like dimer with Gpb1 or Gpb2, a G␤ subunit mimic, and binds to Gpa2, the G␣ subunit responsible for glucose signaling (16) . However, the sequence or architectural resemblance between Gpg1 and the authentic G␥ subunits is relatively low. It is speculated that Gpa2 doses not appear to have an authentic G␤␥ partner and that a G␤␥-like dimer, Gpb1/2•Gpg1, might act as a pseudostructural inhibitor of the glucose/cAMP signaling pathway to negatively regulate haploid inactive, filamentous growth (18).
We might speculate two possible scenarios to explain the inhibition of prion propagation by Gpg1. A straightforward explanation is that Gpg1 binds to the growing tip of a prion aggregate and blocks its rapid growth, leading to its destabilization and loss (''capping'' model; ref. 35) . This is consistent with the finding that Gpg1 is prone to self-aggregate and is able to colocalize with the Sup35NM aggregate in [PSI ϩ ] cells until the dispersion of [PSI ϩ ] foci (see Fig. 4 ). The protein architecture analysis reveals that Gpg1 is largely hydrophobic and possesses two ␣ helices, ␣2 and ␣4, of amphiphilic nature (see Fig. 6 ). Hydrophobic amino acids are clustered on one side of the ␣ helices and are affected by multiple loss-of activity gpg1 mutations. Therefore, we would speculate that the hydrophobic surfaces of ␣2 and ␣4 are involved in a crucial interaction with prion amyloids or some cofactors, which might be impaired by gpg1 mutations. Confocal microscopy observation that disabled Gpg1s are colocalized with [PSI ϩ ] Sup35NM aggregates (see Fig. S5 ) suggests it less likely that the presumed hydrophobic surface serves as a direct interaction site for prion amyloids. The alternative explanation is that over-expression of Gpg1 affects the S. cerevisiae glucose/cAMP signaling pathway and exerts an inhibitory effect on the propagation of yeast prions indirectly by turning on or off downstream effectors. Although this possibility cannot be ruled out completely, we assume this unlikely because gpa2⌬ and gpb1⌬ null mutations did not affect prion maintenance and Gpg1-induced prion elimination.
The GPG1 gene appears to be normally silent (see Fig. 1E ). This situation is favorable for the prion propagation as well as for glucose/cAMP signaling because Gpg1 is a potent inhibitor of (probably) both processes. Therefore, if a physiological or environmental condition exists that induces GPG1 expression, it might operate as a unique regulatory system to turn off prion propagation and change G protein signaling in S. cerevisiae.
Methods
Strains, Plasmids, and Manipulations. S. cerevisiae strains used in the present study are listed in Table S2 . Media and other manipulations, including fluorescence microscopy, colony color-based prion assay, and protein analysis are as described previously except that anti-Gpg1 rabbit polyclonal antibody was prepared against full-length Gpg1 in the present study (15) . To isolate multicopy-plasmid-based antagonists of [PSI ϩ ], S. cerevisiae [PSI ϩ ] strain (NPK265; MATa ade1-14 leu2 ura3-197 his3 trp1) was transformed with a yeast genomic library cloned into pRS423, and the resulting His ϩ transformants were screened for 5-FOA resistance on SGal-his ϩ 5-FOA plates (i.e., Ura Ϫ phenotype) and red colony color on YPD plates (Ade Ϫ phenotype), as described previously (15) . pN5 (see Fig. 1 A) is one such plasmid with a reproducible phenotype to eliminate [PSI ϩ ]. Plasmids used are pRS400 series vectors (Stratagene) and their expression derivatives (designated after the promoter, such as pRS423GPDp or pRS423CUP1p) containing the GPD or CUP1 promoter and the CYC1 terminator for expression of exogenous sequences (15) . Details of plasmid and strain construction and other manipulations are described in the SI Text.
Isolation of Loss-of-Activity gpg1 Mutations. The 0.7-kb fragment containing the GPG1 coding sequence, 5Ј-flanking (GPD promoter) and 3Ј-flanking (CYC1 terminator) sequences was amplified by error-prone PCR in vitro, and cotransformed into the NPK265 ([PSI ϩ ] ade1-14; white) strain with a linearized, BamHI-XhoI, plasmid pRS426 (multicopy 2, URA3) carrying the GPD promoter and CYC1 terminator. The mutagenized gpg1 sequences were inserted in vivo into the vector sequence at the GPD promoter and the CYC1 terminator sequences by homologous recombination. The resulting Ura ϩ transformants were selected on SC-ura plates and replica-plated onto YPD plates to screen for white (i.e., [PSI ϩ ]) colonies. Plasmids that gave a reproducible phenotype were characterized by DNA sequencing and genetic studies.
